prof. MUDr. Alexandra Kolenová, PhD.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti:
1. | Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, ............, Kolenova A, ............ The MLL recombinome of acute leukemias in 2013. Leukemia. 2013. | Q1 | IF 9,379 |
2. | Hrusak O, de Haas V, Stancikova J, Vakrmanova B, .........., Kolenova A, .......... .International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018. | Q1 | IF 16,562 |
3. | Donadieu J, Larabi IA, Tardieu M, ...................., Kolenova A, ............. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study. Journal of clinical oncology. 2019 | Q1 | IF 32,956 |
4. | Hrusak O, Kalina T, Wolf J, .................., Kolenova A, .................. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. European Journal of Cancer. 2020. | Q1 | IF 9,162 |
5. | Novakova M, Zaliova M, Fiser K, ............, Kolenova A, Stuchly J, Zuna J, Trka J, Hrusak O, Mejstrikova E. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 2021 | Q1 | IF 9,941 |